Translate page

The iCMLf Partners


The iCMLf is pleased and proud to work with the following organisations to improve outcomes for people with CML around the world.

The Max Foundation, a US based NGO at the center of access to treatment for CML in developing countriesMAX Foundation

For the past 10 years The Max Foundation has provided services to CML patients in need of access to treatment and support in more than 100 countries. The organization operates through a network of locally based advocates and through close relationships with key opinion leaders in CML, plus more than 1,000 physicians treating CML in developing countries. Every year The Max Foundation provides services to more than 22,000 CML patients.

European School of Haematology (ESH)ESH logo

The European School of Haematology (ESH) is a not-for-profit institution for continuing education founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in haematology.

"CML Advocates Network" fosters collaboration of patient groups

logo_cmladvocates_106Patient groups representing rare cancers like leukaemia greatly benefit from sharing knowledge as well as collaborating with other groups and the oncology community. The CML Advocates Network, founded in 2007, is both a virtual network and an internet platform, now connecting 90 leukemia patient groups from 68 countries.

Alpine Oncology Foundationlogo alpine oncology foundation

Alpine Oncology Foundation's ( principal objective is to help improve the clinical management and optimize outcomes of children and adults diagnosed to have blood cancer by providing educational support and appropriate tools to the patients and their health care professionals, in some of the most economically challenged countries, such as Tanzania. We work closely with global clinical experts and suitable partners, such as the International Chronic Myeloid Leukemia Foundation (iCMLf).